Adhesive Capsulitis
Conditions
Brief summary
This study was conducted to compare the efficacy of hydrodilatation with steroid with hyaluronic acid and steroid for treating adhesive capsulitis.
Detailed description
Design: a prospective, double-blinded, randomized, clinical trial Patient and methods: Patients with adhesive capsulitis for at least 3 months were enrolled and randomly allocated into group 1 (hydrodilatation with steroid ) and group 2 (hydrodilatation with hyaluronic acid and steroid). The patients were evaluated before treatment and were reevaluated 0, 6, and 12 weeks after the beginning of the treatment. Outcomes measures included a pain scale (visual analog scale), range of motion, Shoulder Pain And Disability Index
Interventions
DRUGnormal saline
Ultrasound guided injection using 3ml normal saline
DRUG(Sodium Hyaluronate (Hyruan One , LG)
Ultrasound guided injection using 3ml of Sodium Hyaluronate
DRUGlidocaine hydrochloride
Ultrasound guided injection using 4ml of 2% lidocaine hydrochloride (Xylocaine)
DRUGTriamcinolone Acetonide
ultrasound guided steroid injection using 4ml of 40mg triamcinolone acetonide
Sponsors
Taipei Veterans General Hospital, Taiwan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
Double (Participant, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. age 35-65 years 2. onset of shoulder stiffness since over a month 3. limitation in the passive range of motion (ROM) over 30° when compared with the contralateral side in at least two of these three movements: forward flexion, abduction, or external rotation.
Exclusion criteria
1. ultrasound findings of rotator cuff tears, 2. plain radiography findings of significant glenohumeral joint arthritis, 3. accompanying cervical radiculopathy, 4. systemic inflammatory joint disease, 5. intraarticular injection into the glenohumeral joint within the past 3 months 6. history of surgery on the affected shoulders, 7. regular use of systemic non-steroidal anti-inflammatory drugs or corticosteroids, 8. allergy to corticosteroid or lidocaine.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change in pain intensity | 0, 6, 12weeks | pain intensity was measured by visual analog scale (0-10) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| change in Shoulder Pain And disability index | 0, 6, 12 weeks | The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The SPADI takes 5 to 10 minutes for a patient to complete and is the only reliable and valid region-specific measure for the shoulder. |
| change in glenohumeral joint range of motion | 0, 6, 12weeks | Shoulder flexion, abduction, external rotation and internal rotation were measured with goniometer with patient in supine position. |
Countries
Taiwan
Contacts
Primary ContactJia chi wang
Outcome results
None listed